Advanced search×

Effects of codeine on pregnancy outcome: results from a large population-based cohort study.

Kateřina K Nezvalová-Henriksen, Olav O Spigset, and Hedvig H Nordeng

Eur J Clin Pharmacol 67(12):1253-61 (2011) PMID 21656212 PMCID PMC3214255

Guidelines on codeine safety during pregnancy rely on small studies with inconsistent results, and associations between codeine use during pregnancy and increased risk of congenital malformations remain unsubstantiated.

DOI: 10.1007/s00228-011-1069-5
Version: za2963e q8za7 q8zbe q8zc7 q8zd8 q8ze3 q8zfd q8zg5
View PDF

Similar articles you may find interesting…

  1. Safety of triptans for migraine headaches during pregnancy and breastfeeding.
    Silvia Duong, Pina Bozzo, ... Adrienne Einarson

    Can Fam Physician 56(6):537-9 (2010) PMID 20547518

    QUESTION: A patient who just found out that she is pregnant and suffers from migraine headaches informs me that she has been taking naratriptan. She indicates that she is planning on breastfeeding her baby and might need to continue treatment. How safe are the medications from this class of drugs du...
    PDF not found
  2. Sinomenine protects against ischaemic brain injury: involvement of co-inhibition of acid-sensing ion channel 1a and L-type calcium channels.
    Wen-Ning WN Wu, Peng-Fei PF Wu, ... Jian-Guo JG Chen

    Br J Pharmacol 164(5):1445-59 (2011) PMID 21585344

    View PDF
  3. Evaluation of Caesalpinia pulcherrima Linn. for anti-inflammatory and antiulcer activities.
    Vivek V Sharma and G P GP Rajani

    Indian J Pharmacol 43(2):168-71 (2011) PMID 21572651

    To evaluate the ethanolic and aqueous extracts of aerial parts of Caesalpinia pulcherrima (Linn.) Sw. for anti-inflammatory and antiulcer activities. Anti-inflammatory action of the ethanolic and aqueous extracts of C. pulcherrima (100 and 200 mg/kg b.w.) (CPE and CPA...
    View PDF